We found that deletion of NFIB in a human SCLC cell line and NFIB suppression in cell lines derived from the Rb/p53/TET-Nfib SCLC mouse model led to reduced numbers of viable cells, with increased apoptosis and reduced proliferation (Figure 3). This evidence concerns the gene TP53 and small cell lung carcinoma.